| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/17/2013 | US8609694 Use of pyridin-2-yl-methylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin |
| 12/17/2013 | US8609674 Potassium channel modulators |
| 12/17/2013 | US8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases |
| 12/17/2013 | CA2697051C Substituted-quinoxaline-type piperidine compounds and the uses thereof |
| 12/17/2013 | CA2691961C Catecholamine derivatives and prodrugs thereof |
| 12/17/2013 | CA2652499C Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 12/17/2013 | CA2624449C Use of neboglamine in the treatment of toxicodependency |
| 12/17/2013 | CA2620554C Treatment of autoimmune diseases |
| 12/17/2013 | CA2613874C Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs |
| 12/17/2013 | CA2543045C Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof |
| 12/17/2013 | CA2478997C Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure |
| 12/15/2013 | CA2820236A1 Non-viral nanoparticle-based delivery system |
| 12/13/2013 | DE202013010193U1 Zusammensetzung zur Verwendung in einer Inhalationsvorrichtung und hierfür einsetzbare Inhalationsvorrichtung A composition for use in an inhalation device and which can be used for this purpose inhalation device |
| 12/12/2013 | WO2013184902A1 Chemical transformations of (-)-codeine to afford derivatives of codeine and morphine thereof |
| 12/12/2013 | WO2013184824A1 Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics |
| 12/12/2013 | WO2013184732A1 Crystalline (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]4-penten-2-amine 1,5-naphthalenedisulfonate |
| 12/12/2013 | WO2013184708A1 Pharmaceutical composition for treating inflammation and pain |
| 12/12/2013 | WO2013184703A1 Pharmaceutical composition for treating inflammation and pain |
| 12/12/2013 | WO2013184591A1 Method of prevention of neurological diseases |
| 12/12/2013 | WO2013184209A1 Mif for use in methods of treating subjects with a neurodegenerative disorder |
| 12/12/2013 | WO2013184202A1 Fbxo3 inhibitors |
| 12/12/2013 | WO2013184023A1 Composition for treating multiple sclerosis (variants) |
| 12/12/2013 | WO2013183985A1 Method of treating cognitive impairment and compounds for use therein |
| 12/12/2013 | WO2013183912A1 Method for preparing small amount of chrysanthemum indicum extract usable as anxiety alleviation drug |
| 12/12/2013 | WO2013183718A1 Screening method, protein instability and/or stability inducers, and protein activity assesment |
| 12/12/2013 | WO2013183494A1 Therapeutic agent, treatment method and test method for diseases associated with activation of neutrophils |
| 12/12/2013 | WO2013182972A1 Benzimidazole-proline derivatives |
| 12/12/2013 | WO2013182906A1 Genistein for reducing levels of storage compounds in the treatment and/or prevention of lysosomal storage diseases (lsds) |
| 12/12/2013 | WO2013182862A1 Synergistic therapies of cannabidiol with hypothermia for neuroprotection |
| 12/12/2013 | WO2013182851A1 Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required |
| 12/12/2013 | WO2013182850A1 Isobenzofuran- 5 -yl-oxy- (hetero) aryl - imidazolidine - 2, 4 -dione derivatives modulators of kv3 potassium channels for the treatment of cns disorders. |
| 12/12/2013 | WO2013182638A1 2 -aminothiazinylheteroaryls as bace1 inhibitors for the treatment alzheimer's disease |
| 12/12/2013 | WO2013182411A1 Fluorinated pyridylacetylene derivatives as tracers |
| 12/12/2013 | WO2013182274A1 Imidazo-oxadiazole and imidazo-thiadiazole derivatives |
| 12/12/2013 | WO2013181786A1 Labdane diterpenoid compounds, semen biotae extract, and preparation method and use thereof |
| 12/12/2013 | WO2012148926A8 Neurodegenerative disorders and muscle diseases implicating pufas |
| 12/12/2013 | US20130331769 Methods for treating headaches |
| 12/12/2013 | US20130331568 Acetylene derivatives having mglur 5 antagonistic activity |
| 12/12/2013 | US20130331310 Prodrug of an Ice Inhibitor |
| 12/12/2013 | US20130330821 Neural progenitor cells derived from embryonic stem cells |
| 12/12/2013 | US20130330363 Method of vaccination |
| 12/12/2013 | US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 12/12/2013 | US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 12/12/2013 | US20130330332 Treatment of pemphigus |
| 12/12/2013 | CA2875674A1 Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics |
| 12/12/2013 | CA2875628A1 Imidazo-oxadiazole and imidazo-thiadiazole derivatives |
| 12/12/2013 | CA2875330A1 Method of prevention of neurological diseases |
| 12/12/2013 | CA2875305A1 Fbxo3 inhibitors |
| 12/12/2013 | CA2875054A1 Pharmaceutical composition for treating inflammation and pain |
| 12/12/2013 | CA2875053A1 Pharmaceutical composition for treating inflammation and pain |
| 12/12/2013 | CA2874968A1 Synergistic therapies of cannabidiol with hypothermia for neuroprotection |
| 12/11/2013 | EP2671885A1 Imidazo-oxadiazole and Imidazo-thiadiazole derivatives |
| 12/11/2013 | EP2671879A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND alpha-GLUCOSIDASE INHIBITOR COMPRISING SAME |
| 12/11/2013 | EP2671872A1 Fluorinated pyridylacetylene derivatives as tracers |
| 12/11/2013 | EP2671869A1 Tetrahydroisoquinoline derivative |
| 12/11/2013 | EP2671588A1 Transdermal patch |
| 12/11/2013 | EP2671587A1 Patch preparation |
| 12/11/2013 | EP2671580A1 Use of antioxidants for the treatment of cognitive and behavioural disorders in individuals with fragile x syndrome |
| 12/11/2013 | EP2671578A1 Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent |
| 12/11/2013 | EP2670774A1 Caspase-2 inhibitors |
| 12/11/2013 | EP2670754A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases |
| 12/11/2013 | EP2670752A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
| 12/11/2013 | EP2670744A1 Pyrrole derivatives used as modulators of alpha7 nachr |
| 12/11/2013 | EP2670738A2 1,4 oxazines as bace1 and/or bace2 inhibitors |
| 12/11/2013 | EP2670731A1 Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof. |
| 12/11/2013 | EP2670421A2 Use of icam-1 for prevention or treatment of neurological diseases |
| 12/11/2013 | EP2670409A1 Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
| 12/11/2013 | EP2670406A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
| 12/11/2013 | EP2328414B1 Substituted triazolo-pyridazine derivatives |
| 12/11/2013 | CN1956952B Histamine H3 receptor agents, preparation and therapeutic uses |
| 12/11/2013 | CN103443106A Novel octahydrothienoquinoline derivatives, pharmaceutical compositions comprising the derivatives and uses of the pharmaceutical compositions |
| 12/11/2013 | CN103443098A Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 12/11/2013 | CN103443094A Pyrazole derivative |
| 12/11/2013 | CN103443093A Novel compounds as histamine H3 receptor ligands |
| 12/11/2013 | CN103443092A Pyrrole derivatives used as modulators of alpha7 nachr |
| 12/11/2013 | CN103443075A Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease |
| 12/11/2013 | CN103442766A A 5-HT4 receptor agonist as a prokinetic agent |
| 12/11/2013 | CN103442711A Treatment of cognitive dysfunction in schizophrenia |
| 12/11/2013 | CN103442704A Cystamine analogues for the treatment of parkinson's disease |
| 12/11/2013 | CN103442703A A water soluble composition comprising curcumin having enhanced bioavailability and process thereof |
| 12/11/2013 | CN103442701A Use of nicotinic acetylcholine receptor alpha 7 activators |
| 12/11/2013 | CN103442693A Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same |
| 12/11/2013 | CN103442595A Functional foods comprising diamine oxidase and uses thereof |
| 12/11/2013 | CN103435814A Non-viral genetic vector material and preparation method and application thereof, and brain-targeted gene transfer system and preparation method and application thereof |
| 12/11/2013 | CN103435692A Application of ginseng glycoprotein in medicaments and health-care foods for treating senile dementia |
| 12/11/2013 | CN103435619A Pochonicine analogue or pharmaceutically acceptable salts of pochonicine analogue and application of pochonicine analogue or pharmaceutically acceptable salts of pochonicine analogue |
| 12/11/2013 | CN103435605A Morpholine tetrazole compound, and preparation method and application thereof |
| 12/11/2013 | CN103435571A Tetrahydrobenzothiazole derivative and preparation method thereof |
| 12/11/2013 | CN103435561A Novel D-amino acid oxidase inhibitor and preparation and application thereof |
| 12/11/2013 | CN103435545A Tetrahydroisoquinoline quaternary ammonium salt derivatives as well as preparation method and analgesia application thereof |
| 12/11/2013 | CN103435465A Substituted hydroxydecyl benzoquinone derivative |
| 12/11/2013 | CN103432681A Medicine preparation and device comprising NRG (neuregulin) |
| 12/11/2013 | CN103432596A Method for researching abirritation mechanism of Chinese herbal medicinal ingredients of Xinhuang tablets |
| 12/11/2013 | CN103432574A Application of peroxidase to preparation of drug for preventing and treating cerebrovascular diseases |
| 12/11/2013 | CN103432542A Medicine for preventing stroke and treating stroke sequela, and preparation method of medicine |
| 12/11/2013 | CN103432385A Medicine for peripheral nerve injury postoperation recovery |
| 12/11/2013 | CN103432382A Production technique of compound wine for beauty, freckle removal, chest enlarging and heat clearing of female |
| 12/11/2013 | CN103432378A Traditional Chinese medicine for treating nerve vascular headache |
| 12/11/2013 | CN103432369A Medicament for treating narcotic adverse reactions |
| 12/11/2013 | CN103432359A Application of dragon blood in pharmacy |